glutathion stransferase Overexpression of Glutathione S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications General reaction catalyzed by glutathione

As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes

More details are explained on the GlyNAC benefits page

The stabilization of HIF-1 under low oxygen levels induces the transcription of glutaminase and GDH, facilitating increased -KG production under metabolic stress

Proc Natl Acad Sci USA (1999) 96:22505

Nu bn ang mun c mt sn phm chnh hng, cht lng tt, gi c phi chng, hy lin h vi chng ti c s la chn tt nht

Therefore both B12 and folate deficiency can result in anaemia and intestinal atrophy